C. Aguiar Et Al. , "A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy," ATHEROSCLEROSIS SUPPLEMENTS , vol.19, 2015
Aguiar, C. Et Al. 2015. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy. ATHEROSCLEROSIS SUPPLEMENTS , vol.19 .
Aguiar, C., Alegria, E., Bonadonna, R. C., Catapano, A. L., Cosentino, F., Elisaf, M., ... Farnier, M.(2015). A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy. ATHEROSCLEROSIS SUPPLEMENTS , vol.19.
Aguiar, Carlos Et Al. "A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy," ATHEROSCLEROSIS SUPPLEMENTS , vol.19, 2015
Aguiar, Carlos Et Al. "A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy." ATHEROSCLEROSIS SUPPLEMENTS , vol.19, 2015
Aguiar, C. Et Al. (2015) . "A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy." ATHEROSCLEROSIS SUPPLEMENTS , vol.19.
@article{article, author={Carlos Aguiar Et Al. }, title={A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy}, journal={ATHEROSCLEROSIS SUPPLEMENTS}, year=2015}